Detection of microRNA expression levels based on microarray analysis for classification of idiopathic pulmonary

Qilong Li1, Mohan Li2, Kexin Zheng2

  • 1College of Bioscience and Biotechnology, Shenyang Agricultural University, Shenyang, Liaoning 110866, P.R. China.

Insights

Researchers identified three microRNAs (miRNAs) as potential biomarkers for idiopathic pulmonary fibrosis (IPF). These identified miRNAs show promise for improving IPF diagnosis and understanding disease progression.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Idiopathic pulmonary fibrosis (IPF) etiology and pathophysiology remain incompletely understood.
  • MicroRNAs (miRNAs) are increasingly recognized for their role in IPF progression.

Purpose of the Study:

  • To screen and identify microRNAs (miRNAs) associated with idiopathic pulmonary fibrosis (IPF) using multiple computational algorithms.
  • To validate identified miRNA candidates as potential diagnostic biomarkers for IPF.

Main Methods:

  • Utilized One-way ANOVA, LASSO, and SVM-RFE algorithms for miRNA screening and feature selection.
  • Extracted miRNAs from formalin-fixed paraffin-embedded tissues for detection via RT-qPCR.
  • Validated differential expression of selected miRNAs (miR-124, hsa-miR-524-5p, hsa-miR-194, hsa-miR-133a) in IPF patients.

Main Results:

  • Identified three miRNA candidates (miR-124, hsa-miR-524-5p, hsa-miR-194) through the intersection of three algorithms.
  • Achieved a diagnostic area under the curve of 78.5% for discriminating IPF from controls using a receiver operating characteristic model.
  • Confirmed differential expression of miR-124, hsa-miR-524-5p, hsa-miR-194, and hsa-miR-133a in IPF patients compared to controls.

Conclusions:

  • The identified miRNAs (miR-124, hsa-miR-524-5p, hsa-miR-194) show potential as diagnostic biomarkers for IPF.
  • These miRNAs may contribute to understanding IPF pathogenesis.
  • Further research into miRNA targets and pathways could elucidate IPF mechanisms.